It requires medical supervision to ensure it is safe for your health and to monitor potential side effects
Food and Drug Administration (FDA) approved Eli Lilly and Companys (NYSE: LLY) Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
TB-500 is the synthetic variant of the naturally occurring Thymosin Beta-4, found in both human and animal cells
Lighting, sleep, makeup, recent skincare, camera settings, and natural day-to-day variation can also make a before-and-after image look more dramatic than the treatment itself
The window of opportunity that the FDA describes will not remain open long, and stakeholders prescribing, receiving, or dispensing compounded semaglutide injection products need to take immediate action to plan and adapt accordingly